Tana M - Search Results

1

Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.

Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K. Yilma M, et al. Among authors: tana m. JAMA Netw Open. 2023 Jun 1;6(6):e2317549. doi: 10.1001/jamanetworkopen.2023.17549. JAMA Netw Open. 2023. PMID: 37289453 Free PMC article.

2

Autoantibodies in hepatitis C: red flag or bystander effect?

Tana MM, Heller T. Tana MM, et al. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):243. doi: 10.1097/MPG.0b013e3182774b04. J Pediatr Gastroenterol Nutr. 2013. PMID: 23443062 Free PMC article. No abstract available.

3

Hepatitis B virus treatment: Management of antiviral drug resistance.

Tana MM, Ghany MG. Tana MM, et al. Clin Liver Dis (Hoboken). 2013 Mar 1;2(1):24-28. doi: 10.1002/cld.162. eCollection 2013 Feb. Clin Liver Dis (Hoboken). 2013. PMID: 30992816 Free PMC article. Review. No abstract available.

4

Scar undone: long-term therapy of hepatitis B.

Tana MM, Hoofnagle JH. Tana MM, et al. Lancet. 2013 Feb 9;381(9865):433-4. doi: 10.1016/S0140-6736(12)61721-8. Epub 2012 Dec 10. Lancet. 2013. PMID: 23234726 No abstract available.

5

Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?

Tana MM, Muir AJ. Tana MM, et al. Clin Gastroenterol Hepatol. 2018 Jan;16(1):16-18. doi: 10.1016/j.cgh.2017.06.050. Epub 2017 Jul 8. Clin Gastroenterol Hepatol. 2018. PMID: 28694131 No abstract available.

6

Barriers to liver transplant referral in safety net settings: A national provider survey.

Hundt M, Chen A, Donovan J, Kim N, Yilma M, Tana M, Mehta N, Zhou K. Hundt M, et al. Among authors: tana m. Liver Transpl. 2024 Sep 1;30(9):896-906. doi: 10.1097/LVT.0000000000000384. Epub 2024 May 1. Liver Transpl. 2024. PMID: 38687168

7

Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use.

Patel S, Kim RG, Shui AM, Magee C, Lu M, Chen J, Tana M, Huang CY, Khalili M. Patel S, et al. Among authors: tana m. Gastro Hep Adv. 2024;3(1):84-94. doi: 10.1016/j.gastha.2023.09.012. Epub 2023 Oct 5. Gastro Hep Adv. 2024. PMID: 39100862 Free PMC article.

8

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.

Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, Parekh P, Shui AM, Cheung R, Monto A, Wong RJ, Chen JY, Liao M, Tana M, Chen PH, Haight CG, Fakadej T, Khalili M. Satre DD, et al. Among authors: tana m. Aliment Pharmacol Ther. 2024 Nov 11. doi: 10.1111/apt.18387. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39523996

9

Obesity and metabolic outcomes in a safety-net health system.

Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M. Huynh MP, et al. Among authors: tana mm. Biodemography Soc Biol. 2020 Jul-Sep;65(3):257-267. doi: 10.1080/19485565.2020.1765732. Biodemography Soc Biol. 2020. PMID: 32727275 Free PMC article.

10

Factors associated with the platelet count in patients with chronic hepatitis C.

Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Tana MM, et al. Thromb Res. 2015 May;135(5):823-8. doi: 10.1016/j.thromres.2015.02.010. Epub 2015 Feb 19. Thromb Res. 2015. PMID: 25728497 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters